ClearAlpha Technologies LP

Position in NVS — Novartis AG

CIK 1972331 Greenwich, CT

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$588,797

+$18,276 QoQ

Shares Held

3,757

+0.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.03%

of 13F equity value

Holder Rank

#821

of 1,603 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ClearAlpha Technologies LP holds $2,503,646 across 3 Drug Manufacturers - General names. NVS ranks #3 (23.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	8,030	$1,014,510
2	SNY	Sanofi	21,105	$900,339
3	NVS	Novartis AG This page	3,757	$588,797

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$588,797	3,757	+0.6%	Shares	Sole	2026-08-14
2026-03-31	$570,521	3,735	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.